Rosalind Franklin University Helix 51 Incubator Company BLR Bio Presents Promising New Scleroderma Drug Data at International Rheumatology Meeting

P BLR-200 demonstrates unique mechanism blocking activation of scar-forming cells in systemic sclerosis models NORTH CHICAGO, Ill., April 30, 2026 /PRNewswire/ — Rosalind Franklin University…
posteditor
posteditor
Articles: 27509

Other News